hotspot -WSS

hotspot

author：comprehensive 2025-10-01 12:34:55 - browse：18

Telehealth menopause treatment options displayed on cellphones emerging from a crack in the ground. -- health tech coverage from STAT — Molly Ferguson for STAT

At the turn of the century, nearly 18 million women in the United States were battling hot flashes, night sweats, and other symptoms of menopause with hormones. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease. The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.

More than two decades later, menopause experts have come to think about the results of the trial very differently. Newer research points to more benefits than risks for many healthy women under 60 treating menopause symptoms with hormone therapy. But many women who are good fits still aren’t getting treatment. “The pendulum has been slowly — too slowly — swinging back,” said OB-GYN Mike Green, chief medical officer of menopause telehealth company Winona.

Winona is part of a new generation of virtual-first health care companies aiming to give that pendulum a push. In the last five years, more than a dozen telehealth companies have started up to serve women in and approaching menopause, including with hormone therapy.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Judge rejects Trump's request to move Stormy Daniels hush

knowledge

entertainment

WSS

I learned firsthand about improving diversity in clinical trials

Ebola vaccine can save some who are already sick, per new study

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Too many hospitalized Covid

Judge rejects Trump's request to move Stormy Daniels hush

Latigo launches with $135 million for Vertex

explore

hotspot

focus

Medical leaders decry Supreme Court decision on affirmative action

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Peter Hotez and the public health issue of online harassment

Eli Lilly reports tirzepatide MASH success during Q4 earnings

New air purifier tech could be key to improving indoor air quality

Stanford president's case begs question: Who takes blame?

Psychedelics group wrestles with new pharma identity

Ending racial health disparities hinges on penalties, political will

After affirmative action ruling, medical educators look to 'holistic review'

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

focus

Affordable Connectivity Program vital to health care, experts say

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Indian pharmaceutical industry in denial over drug

Latigo launches with $135 million for Vertex

Driven by the pandemic, applicants flood public health schools

Having children helps parents live longer, especially after age 80

knowledge

entertainment

focus

focus